MGAT3 and melanoma: It has been shown that overexpression of GnT-III (MGAT3) in highly metastatic mouse melanoma B16 cells led to a decreased synthesis of β1,6-branching through the competition for substrate between GnT-V and the overexpressed GnT-III.